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Management of a DKA patient with severe metabolic and ketoacidosis with chronic renal insufficiency
Brian Albany BSN, CCRN
Otterbein University, Westerville, Ohio
Introduction

Case Study

Diabetic ketoacidosis (DKA)
serves as one the leading causes of
mortality in diabetic patients [14].
The mortality has decreased over
the past several decades due to the
rapid recognition of the disease
state and the improvement of
management of DKA [14]. Despite a
decline in mortality rates over the
past twenty years from 7.96% to
0.67%, errors in management of the
disease state are associated with
significant morbidity and mortality
[2]. Utilization of DKA protocols in
the acute care setting have allowed
congruency in care and delivery of
effective lifesaving treatment.
Despite advances in standardized
DKA protocols, there still remains a
gap in how to manage specific
patient populations with end stage
renal disease. Understanding the
pathophysiology behind these
patient populations will yield better
outcomes with the ultimate goal of
decreasing the mortality rate.

A 55 year old female patient with a
past medical history of type one
diabetes and end-stage renal disease
presents to the intensive care unit with
diabetic ketoacidosis. The patient had
the following lab values:
•
•
•
•
•
•
•

Underlying
Pathophysiology

Glucose-1,107 mg/dL
Beta hydroxybutyrate-7.6
mg/dL
Anion Gap-36 mEq/l
Creatinine-4.54 mg/dL
BUN-80 mg/dL
GFR-<5ml/min
Lactate-4.1 mg/dL

ABG:
•
pH-6.85
•
Co2-12 mmHg
•
HCO3-1.9 mmol/L
•
PO2-197 mmHg
These lab values indicate the
combination of severe ketoacidosis from
DKA and metabolic acidosis related to
chronic renal insufficiency.
The patient arrives to the intensive
care unit with an intact neurological
status, stable vital signs, and on room
air. The nurse titrated the insulin drip
per hospital’s DKA policy. This policy
states that the nurse is able to double
the insulin infusion rate if the blood
glucose level has not decreased after
initiating the drip. The patient’s blood
glucose had not improved despite
intravenous IV insulin; therefore, the
nurse titrated the drip up to 100
units/hr. At the same time, the patient
received 2 amps of sodium bicarbonate
IV push and was started on a sodium
bicarbonate infusion. After some time,
the patient’s labs started to trend in the
right direction with a closing anion gap,
decrease in glucose level, increase in pH
and decrease in ketone levels. The
insulin infusion rate ran at a rate of
100units/hr for a total of 5 hours then it
was weaned off based on the closure of
the anion gap and decrease in the
patient’s glucose level.
During day shift, the patients’ blood
glucose plummeted into the low 40s on
three different occasions. Each time, the
nurse gave 1 amp of Dextrose 50%.

Figure 1: Pathological process of
DKA [15]
DKA develops as a result deficient
levels of insulin circulating throughout the
body causing a triad of hyperglycemia,
hyperketonemia, and acidosis [10,14].
Counterregulatory hormones consisted of
catecholamines, glucagon, and cortisol are
activated in a state of insulin deficiency
ultimately causing an increased blood
glucose level. The glucagon activates
gluconeogenesis in the liver to form more
glucose and the body starts to break down
adipose tissue through lipolysis which
yields free fatty acids and a state of
hyperketonemia. The circulating ketones
induces a state of acidosis with a
decreased bicarbonate reserve. Severe
dehydration and electrolyte abnormalities
occur as the result of osmotic diuresis
associated with the hyperglycemic state
[10].
Patients with chronic kidney disease
often develop a common complication of
metabolic acidosis [3,7]. A state of ph
homeostasis is usually maintained by the
functional units of the kidneys or nephrons
through the excretion of ammonia with a
normal glomerular filtration rate (GFR).
When the GFR reaches a dysfunctional
state of below 40ml/min, there is a
decrease in ammonium excretion and an
increase in hydrogen ion retention causing
a state of acidosis [3]. Other key factors
that contribute to the acidosis are the
decreased synthesis of the acid buffer
bicarbonate and the increased excretion of
the bicarbonate through the
gastrointestinal and urinary tract [7].

Significance of Pathophysiology
Healthcare providers are able to tailor case-specific treatment through an indepth analysis and dissection on the pathophysiological processes associated with a
patient in DKA with a comorbidity of chronic kidney disease. The goal of treatment
for DKA is to reduce serum glucose levels and ketoacidosis through the
administration of parental insulin. This will ultimately result in the improvement of
acidosis and will produce a state of acid-base homeostasis. This may not be an
effective solution to follow in patients who present with severe metabolic and
ketoacidosis.
Insulin resistance is defined as “a clinical condition where there is a reduced
biological effect for any given blood concentration of insulin,” [8]. It is characterized
as reduced tissue responses to the action of insulin [1]. One study concluded that
there is a direct relationship between a lower serum bicarbonate and high anion
gap which are both independently associated with reduced insulin sensitivity [4].
The data from this study supports the hypothesis that the production of organic
acid serves as a central feature of insulin resistance [4]. The use of alkali therapy in
DKA is controversial because the acidosis should correct itself through the
administration of insulin and fluids; however, many studies show that insulin
sensitivity is decreased in uremic patients; therefore, treatment of metabolic
acidosis through alkali therapy is necessary in achieving a decrease in insulin
resistance with patients that also present with end stage renal disease [1,9,11,13].
Data suggests that acidosis should be corrected as soon as possible which will
result in increased insulin sensitivity to lower blood glucose levels and decrease
lipolysis [6]. The exogenous insulin given to treat patients in DKA is insensitive and
ineffective without neutralizing the blood pH through bicarbonate therapy in such
extreme circumstances. The American Diabetes Association states how severe
acidosis in hyperglycemic crises can lead to more adverse effects and that adult
patients with a pH < 6.9 should receive sodium bicarbonate until pH>7.0 is
achieved [5].
The kidneys play a major role in metabolism of insulin [12]. Approximately
25% of daily insulin production is degraded by the kidneys [12]. Renal metabolism
is augmented in diabetic patient’s receiving exogenous insulin because the insulin
bypasses filtration through the liver when injected into the systemic circulation
[12]. Since the renal clearance of insulin is 200ml/min, patients with an impaired
GFR will have unfiltered insulin freely circulating in the body [12]. This becomes
significant when treating a DKA patient with renal insufficiency. Administering
exogenous IV insulin to this patient without correcting the patient’s acidosis can
result in serious adverse outcomes and even death by inducing a state of
hypoglycemia. The patient’s extreme metabolic acidosis will result in a decreased
insulin sensitivity and a decreased ability to filter insulin out of the body; therefore,
the patient is at risk for developing hypoglycemia when the acidosis is corrected.
This concept was evident in the case study when the patient’s blood glucose levels
had dramatically declined the following day due to increased levels of circulating
insulin along with the correction of the patient’s acidosis

Figure 2: Three elements of DKA [16]

Implications for nursing care
•
•
•
•
•
•
•

Identify if the patient with DKA has
renal insufficiency
Draw serial labs: Chem 7, Beta
hydroxybutyrate, and ABGs q 6
hours
Consult with physician to obtain
order to administer sodium
bicarbonate if pH<6.9
Monitor hourly blood glucose level
Follow DKA protocol for fluid
management strategy
Provide electrolyte
supplementation as blood glucose
levels normalize
Call physician to transition patient
onto subcutaneous insulin when
anion gap closes

Conclusion
The current standardized
DKA protocols do not address
patients with renal insufficiency.
Treatment for diabetic patients
in DKA with chronic kidney
disease should revolve around
correcting extreme metabolic
acidosis states (pH<6.9) before
the administration of parental
insulin. This approach will
increase insulin sensitivity and
utilization to decrease blood
glucose levels and halt the
process of lipolysis, ultimately
resolving DKA.
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